{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:54:05Z","timestamp":1785545645512,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.clinre.2024.102402","type":"journal-article","created":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T06:54:04Z","timestamp":1718952844000},"page":"102402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3325-6216","authenticated-orcid":false,"given":"Achuthan","family":"Sourianarayanane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5901-638X","authenticated-orcid":false,"given":"Christopher R.","family":"Brydges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4906-0034","authenticated-orcid":false,"given":"Arthur J","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clinre.2024.102402_bib0001","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2024.102402_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102402_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-2003-39781","article-title":"Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes","volume":"111","author":"Boden","year":"2003","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.clinre.2024.102402_bib0004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fendo.2020.00505","article-title":"Too much of a good thing? An evolutionary theory to explain the role of ceramides in NAFLD","volume":"11","author":"Poss","year":"2020","journal-title":"Front Endocrinol"},{"issue":"9","key":"10.1016\/j.clinre.2024.102402_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095146","article-title":"Lipotoxicity as the leading cause of non-alcoholic steatohepatitis","volume":"23","author":"Brankovi\u0107","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.clinre.2024.102402_bib0006","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1055\/s-0033-1358521","article-title":"The lipid droplet as a potential therapeutic target in NAFLD","volume":"33","author":"Goh","year":"2013","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0007","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cld.2015.10.007","article-title":"Nonalcoholic fatty liver disease: lipids and insulin resistance","volume":"20","author":"Berk","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0008","doi-asserted-by":"crossref","first-page":"E423","DOI":"10.1152\/ajpendo.00133.2016","article-title":"Targeting ceramide metabolism in obesity","volume":"311","author":"Aburasayn","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clinre.2024.102402_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.569250","article-title":"The role of ceramides in diabetes and cardiovascular disease regulation of ceramides by adipokines","volume":"11","author":"Field","year":"2020","journal-title":"Front Endocrinol"},{"issue":"8","key":"10.1016\/j.clinre.2024.102402_bib0010","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.clinre.2024.102402_bib0011","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1194\/jlr.P035808","article-title":"Plasma lipid profiling in a large population-based cohort","volume":"54","author":"Weir","year":"2013","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0012","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/jcmm.13984","article-title":"The relationship between phospholipids and insulin resistance: from clinical to experimental studies","volume":"23","author":"Chang","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10.1016\/j.clinre.2024.102402_bib0013","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1038\/nutd.2016.27","article-title":"Plasma phospholipids and fatty acid composition differ between liver biopsy-proven nonalcoholic fatty liver disease and healthy subjects","volume":"6","author":"Ma","year":"2016","journal-title":"Nutr Diabetes"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0014","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2024.102402_bib0015","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2024.102402_bib0016","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021034","article-title":"Phosphatidylethanolamines are associated with nonalcoholic fatty liver disease (NAFLD) in obese adults and induce liver cell metabolic perturbations and hepatic stellate cell activation","volume":"24","author":"Shama","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.clinre.2024.102402_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clinre.2024.102402_bib0019","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ijbs.78525","article-title":"Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease","volume":"19","author":"Zhu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.clinre.2024.102402_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.clinre.2024.102402_bib0021","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.metabol.2016.01.011","article-title":"Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity","volume":"65","author":"Walle","year":"2016","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.clinre.2024.102402_bib0022","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1054\/clnu.2001.0529","article-title":"Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis","volume":"21","author":"de Almeida","year":"2002","journal-title":"Clin Nutr"},{"issue":"8","key":"10.1016\/j.clinre.2024.102402_bib0023","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/MEG.0b013e32835f0786","article-title":"Alcoholic liver disease\/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease","volume":"25","author":"Cerovi\u0107","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.clinre.2024.102402_bib0024","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102402_bib0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","article-title":"Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics","volume":"49","author":"Matyash","year":"2008","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.clinre.2024.102402_bib0026","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41587-020-0531-2","article-title":"A lipidome atlas in MS-DIAL 4","volume":"38","author":"Tsugawa","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.clinre.2024.102402_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2022.101997","article-title":"Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: an NHANES analysis","volume":"46","author":"Sourianarayanane","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2024.102402_bib0028","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jhep.2022.11.010","article-title":"A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes","volume":"78","author":"Ajmera","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2024.102402_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1051807","article-title":"Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese","volume":"13","author":"Jiang","year":"2022","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.clinre.2024.102402_bib0030","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.clinre.2024.102402_bib0031","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.clinre.2024.102402_bib0032","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102402_bib0033","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa739","article-title":"Time-of-day and meal size effects on clinical lipid markers","volume":"106","author":"Grant","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.clinre.2024.102402_bib0034","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1872-034X.2011.00815.x","article-title":"Weight loss amelioration of non-alcoholic steatohepatitis linked to shifts in hepatic ceramide expression and serum ceramide levels","volume":"41","author":"Promrat","year":"2011","journal-title":"Hepatol Res"},{"issue":"2","key":"10.1016\/j.clinre.2024.102402_bib0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0026-0495(84)90121-5","article-title":"Study on lipid metabolism in obesity diabetes","volume":"33","author":"Golay","year":"1984","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.clinre.2024.102402_bib0036","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.3889\/oamjms.2019.312","article-title":"Correlation between obesity and lipid profile in type 2 diabetes mellitus patients at the endocrine and metabolic polyclinic in general hospital Pirngadi Medan","volume":"7","author":"Silitonga","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"issue":"12","key":"10.1016\/j.clinre.2024.102402_bib0037","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1111\/liv.15059","article-title":"The role of hepatic lipid composition in obesity-related metabolic disease","volume":"41","author":"Willis","year":"2021","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.clinre.2024.102402_bib0038","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2014.11.008","article-title":"Effect of glucagon-like peptide-1 receptor agonists on lipid profiles among type 2 diabetes: a systematic review and network meta-analysis","volume":"37","author":"Sun","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinre.2024.102402_bib0039","article-title":"GLP-1 receptor agonists for the treatment of obesity: role as a promising approach","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"issue":"12","key":"10.1016\/j.clinre.2024.102402_bib0040","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clinre.2024.102402_bib0041","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102402_bib0042","doi-asserted-by":"crossref","first-page":"e0100","DOI":"10.1097\/CLD.0000000000000100","article-title":"Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD","volume":"23","author":"Shah","year":"2024","journal-title":"Clin Liver Dis"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124001232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T06:13:57Z","timestamp":1723011237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124001232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2210740124001232"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102402","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liver tissue lipids in metabolic dysfunction-associated steatotic liver disease with diabetes and obesity","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102402"}}